- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00808535
Cardiac Magnetic Resonance Imaging for Detecting Endothelial Dysfunction
A Pilot Study of Cardiac Magnetic Resonance Imaging For Detection of Myocardial Perfusion Abnormalities in Endothelial Dysfunction
The goal of this research study is to demonstrate that Cardiac Perfusion MRI with Vasomotor Stress may serve as a non-invasive and less risky imaging technique for detecting non-obstructive perfusion deficits and/or abnormalities in myocardial blood flow (MBF) in patients with endothelial dysfunction.
This is a controlled study, which will enroll approximately 60 subjects (30 diabetics and 30 non-diabetics to serve as healthy controls), and will include male and non-pregnant females, between the ages 18-50 years.
All eligible participants will sign an informed consent and will complete a Lifestyle Questionnaire. They will undergo blood work which includes:
- 2-hour Oral Glucose Tolerance Test and Fasting Labs for Glucose, Insulin, C-Peptide, HbA1c, Creatinine, and Lipid Panel.
- Urine Albumin to Creatinine ratio for microalbuminuria.
- Serum inflammatory markers: E-selectin, homocysteine, ADMA, VCAM, IL-6, TNFalpha, hs-CRP and PAI-1.
After blood work, all participants will undergo cardiac MR perfusion imaging procedure with Cold Pressor Test and Adenosine Stress Test.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
California
-
Los Angeles, California, United States, 91324
- UCLA Radiological Sciences
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Diagnosed diabetics (less than 5 years) without documented coronary artery disease recruited from UCLA Ambulatory clinics.
Healthy controls from general population.
Description
Inclusion Criteria:
- Age 18 to 50 years
- Should be able to sign an informed consent and HIPAA Agreement
- 30 healthy, non-diabetic individuals
- 30 diabetic individuals without documented coronary artery disease
- Diagnosed diabetics less than 5 years
- HbA1c less than 8.0
Exclusion Criteria:
- Children under 18 years and adults above 50 years
- Type 1 DM
- Lactating and Pregnant females
- BMI less than 35
- Contraindication to MRI such as pacemaker, defibrillator implants, etc.
- Allergy to MR (paramagnetic) contrast
- History of Angina, MI, or documented Coronary Artery Disease
- Previous history of CHF, CABG, Angioplasty and Stenting
- History of Valvular Heart Disease and Congenital Heart Disease
- History of Peripheral Vascular Disease
- History of Cardiac Arrythmias and anti-coagulation therapy
- History of Cerebro-vascular accidents or TIA
- History of active diabetic retinopathy and nephropathy
- Uncontrolled hypertension (systolic > 170 and diastolic >100 mm Hg
- End Stage Renal Disease and patients on dialysis
- HbA1c of 8.0
- Creatinine greater than 1.7 mg/dl
- History of active gastrointestinal bleeding
- History of IV drug use
- Chronic or current steroid treatment
- Growth hormone treatment
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
healthy controls
|
All participants will undergo Cardiac Perfusion MRI with Vasomotor Stress.
Vasomotor Stress will include both Cold Pressor Test and Adenosine Stress Test.
|
|
diabetics
|
All participants will undergo Cardiac Perfusion MRI with Vasomotor Stress.
Vasomotor Stress will include both Cold Pressor Test and Adenosine Stress Test.
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Stefan Ruehm, MD, University of California, Los Angeles
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CMRI_Perfusion Study
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.